Eli Lilly to supply 400000 tablets of its COVID-19 treatment to India

Eli Lilly and Co (LLY.N) said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to the Indian government as the country fights a raging pandemic that has morgues and hospitals overflowing. With 3.45 million active cases, India recorded 357,229 new infections over the last 24 hours, while deaths rose 3,449 for a toll of 222,408, health ministry data showed. Experts say actual numbers could be five to 10 times higher, however. The drugmaker said it will work urgently to increase the supply multifold over the coming weeks.